These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7521092)

  • 1. A modified prostatic UroLume Wallstent for healthy patients with symptomatic benign prostatic hyperplasia: a European Multicenter Study.
    Guazzoni G; Montorsi F; Coulange C; Milroy E; Pansadoro V; Rubben H; Sarramon JP; Williams G
    Urology; 1994 Sep; 44(3):364-70. PubMed ID: 7521092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The North American experience with the UroLume endoprosthesis as a treatment for benign prostatic hyperplasia: long-term results. The North American UroLume Study Group.
    Oesterling JE; Kaplan SA; Epstein HB; Defalco AJ; Reddy PK; Chancellor MB
    Urology; 1994 Sep; 44(3):353-62. PubMed ID: 7521091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostatic UroLume Wallstent for benign prostatic hyperplasia patients at poor operative risk: clinical, uroflowmetric and ultrasonographic patterns.
    Guazzoni G; Bergamaschi F; Montorsi F; Consonni P; Galli L; Matozzo V; Rigatti P
    J Urol; 1993 Nov; 150(5 Pt 2):1641-6; discussion 1646-7. PubMed ID: 7692102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of transrectal hyperthermia, transurethral thermotherapy, urolume wallstent, and prostatic spiral for benign prostatic hyperplasia patients at poor operative risk.
    Montorsi F; Guazzoni G; Bergamaschi F; Consonni P; Galli L; Rigatti P
    Prostate; 1994; 24(3):156-61. PubMed ID: 7509486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The UroLume endoprosthesis: a summary of the European and North American experience.
    Oesterling JE
    Prog Clin Biol Res; 1994; 386():561-75. PubMed ID: 7528427
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term clinical results and quality of life after insertion of a self-expanding flexible endourethral prosthesis.
    Anjum MI; Chari R; Shetty A; Keen M; Palmer JH
    Br J Urol; 1997 Dec; 80(6):885-8. PubMed ID: 9439402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 12-year outcome analysis of an endourethral wallstent for treating benign prostatic hyperplasia.
    Masood S; Djaladat H; Kouriefs C; Keen M; Palmer JH
    BJU Int; 2004 Dec; 94(9):1271-4. PubMed ID: 15610103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The UroLume stent in the management of benign prostatic hyperplasia.
    Milroy E; Chapple CR
    J Urol; 1993 Nov; 150(5 Pt 2):1630-5. PubMed ID: 7692100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epithelializing stent for benign prostatic hyperplasia: a systematic review of the literature.
    Armitage JN; Cathcart PJ; Rashidian A; De Nigris E; Emberton M; van der Meulen JH
    J Urol; 2007 May; 177(5):1619-24. PubMed ID: 17437773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcome of prostatic stent treatment for benign prostatic hyperplasia.
    Chiou RK; Chen WS; Akbari A; Foley S; Lynch B; Taylor RJ
    Urology; 1996 Oct; 48(4):589-93. PubMed ID: 8886065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostatic spiral versus prostatic urolume wallstent for urinary retention due to benign prostatic hyperplasia. A long-term comparative study.
    Guazzoni G; Montorsi F; Bergamaschi F; Consonni P; Bellinzoni P; Rigatti P
    Eur Urol; 1993; 24(3):332-6. PubMed ID: 7505225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of wallstents in patients with benign prostatic hyperplasia.
    Guazzoni G; Montorsi F; Rigatti P
    Arch Esp Urol; 1994 Nov; 47(9):927-31. PubMed ID: 7530950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A permanent, epithelializing stent for the treatment of benign prostatic hyperplasia. Preliminary results.
    Oesterling JE
    J Androl; 1991; 12(6):423-8. PubMed ID: 1722799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy and complications of intraprostatic prosthesis in the treatment of benign hyperplasia of the prostate].
    Clemente Ramos L; Burgos Revilla FJ; Fernández Fernández E; Jiménez Cidre M; Cruz Guerra N; Escudero Barrilero A
    Arch Esp Urol; 1997 Sep; 50(7):773-80. PubMed ID: 9412383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A good alternative to indwelling catheter owing to benign prostate hyperplasia in elderly: Memotherm prostatic stent.
    Bozkurt IH; Yalcinkaya F; Sertcelik MN; Zengin K; Ekici M; Yigitbasi O
    Urology; 2013 Nov; 82(5):1004-7. PubMed ID: 23992964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The urolume, a permanently implanted prostatic stent for patients at high risk for surgery. Results from 5 collaborative centres.
    Williams G; Coulange C; Milroy EJ; Sarramon JP; Rubben H
    Br J Urol; 1993 Sep; 72(3):335-40. PubMed ID: 7693296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of urodynamics in implantation of prostatic stents].
    Comeri G; Conti G; Cretarola E; Furgoni P; Gianneo E
    Arch Ital Urol Androl; 1995 Feb; 67(1):81-5. PubMed ID: 7538397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Long-term results of wall stent implantation in benign prostatic hyperplasia and high risk status].
    Goepel M; Senge A; Otto T; Rübben H
    Urologe A; 1997 Mar; 36(2):151-6. PubMed ID: 9199043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Initial experiences with the Memotherm Stent in treatment of benign prostatic hyperplasia].
    Gottfried HW; Schimers HP; Gschwend J; Brändle E; Hautmann R
    Urologe A; 1995 Mar; 34(2):110-8. PubMed ID: 7538708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of UroLume as an alternative to the treatment of recurrent stenosis of bulbar urethra and obstructive prostatic hyperplasia in patients with high surgical risk].
    Serrano-Brambila EA; Camacho-Carvajal JC; Moreno-Aranda J; Martínez-Sánchez R
    Gac Med Mex; 2003; 139(5):435-48. PubMed ID: 14635562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.